GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Sera Prognostics Inc (NAS:SERA) » Definitions » Piotroski F-Score

Sera Prognostics (Sera Prognostics) Piotroski F-Score

: 4 (As of Today)
View and export this data going back to 2021. Start your Free Trial

The zones of discrimination were as such:

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

Sera Prognostics has an F-score of 4 indicating the company's financial situation is typical for a stable company.

The historical rank and industry rank for Sera Prognostics's Piotroski F-Score or its related term are showing as below:

SERA' s Piotroski F-Score Range Over the Past 10 Years
Min: 2   Med: 4   Max: 4
Current: 4

During the past 5 years, the highest Piotroski F-Score of Sera Prognostics was 4. The lowest was 2. And the median was 4.


Sera Prognostics Piotroski F-Score Historical Data

The historical data trend for Sera Prognostics's Piotroski F-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sera Prognostics Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
Piotroski F-Score
N/A N/A 4.00 2.00 4.00

Sera Prognostics Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Piotroski F-Score Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.00 3.00 3.00 2.00 4.00

Competitive Comparison

For the Diagnostics & Research subindustry, Sera Prognostics's Piotroski F-Score, along with its competitors' market caps and Piotroski F-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Sera Prognostics Piotroski F-Score Distribution

For the Medical Diagnostics & Research industry and Healthcare sector, Sera Prognostics's Piotroski F-Score distribution charts can be found below:

* The bar in red indicates where Sera Prognostics's Piotroski F-Score falls into.


How is the Piotroski F-Score calculated?

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Dec23) TTM:Last Year (Dec22) TTM:
Net Income was -10.565 + -10.542 + -7.21 + -7.925 = $-36.24 Mil.
Cash Flow from Operations was -4.881 + -7.948 + -7.594 + -6.765 = $-27.19 Mil.
Revenue was 0.1 + 0.123 + 0.042 + 0.041 = $0.31 Mil.
Gross Profit was 0.038 + 0.043 + -0.002 + 0.017 = $0.10 Mil.
Average Total Assets from the begining of this year (Dec22)
to the end of this year (Dec23) was
(116.329 + 105.61 + 96.68 + 90.057 + 95.441) / 5 = $100.8234 Mil.
Total Assets at the begining of this year (Dec22) was $116.33 Mil.
Long-Term Debt & Capital Lease Obligation was $0.84 Mil.
Total Current Assets was $61.34 Mil.
Total Current Liabilities was $24.44 Mil.
Net Income was -12.208 + -11.52 + -10.712 + -9.746 = $-44.19 Mil.

Revenue was 0.038 + 0.078 + 0.087 + 0.065 = $0.27 Mil.
Gross Profit was 0.018 + 0.022 + 0.029 + 0.006 = $0.08 Mil.
Average Total Assets from the begining of last year (Dec21)
to the end of last year (Dec22) was
(147.029 + 134.865 + 125.056 + 116.561 + 116.329) / 5 = $127.968 Mil.
Total Assets at the begining of last year (Dec21) was $147.03 Mil.
Long-Term Debt & Capital Lease Obligation was $1.85 Mil.
Total Current Assets was $90.13 Mil.
Total Current Liabilities was $15.54 Mil.

*Note: If the latest quarterly/semi-annual/annual total assets data is 0, then we will use previous quarterly/semi-annual/annual data for all the items in the balance sheet.

Profitability

Question 1. Return on Assets (ROA)

Net income before extraordinary items for the year divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

Sera Prognostics's current Net Income (TTM) was -36.24. ==> Negative ==> Score 0.

Question 2. Cash Flow Return on Assets (CFROA)

Net cash flow from operating activities (operating cash flow) divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

Sera Prognostics's current Cash Flow from Operations (TTM) was -27.19. ==> Negative ==> Score 0.

Question 3. Change in Return on Assets

Compare this year's return on assets (1) to last year's return on assets.

Score 1 if it's higher, 0 if it's lower.

ROA (This Year)=Net Income/Total Assets (Dec22)
=-36.242/116.329
=-0.31154742

ROA (Last Year)=Net Income/Total Assets (Dec21)
=-44.186/147.029
=-0.30052575

Sera Prognostics's return on assets of this year was -0.31154742. Sera Prognostics's return on assets of last year was -0.30052575. ==> Last year is higher ==> Score 0.

Question 4. Quality of Earnings (Accrual)

Compare Cash flow return on assets (2) to return on assets (1)

Score 1 if CFROA > ROA, 0 if CFROA <= ROA.

Sera Prognostics's current Net Income (TTM) was -36.24. Sera Prognostics's current Cash Flow from Operations (TTM) was -27.19. ==> -27.19 > -36.24 ==> CFROA > ROA ==> Score 1.

Funding

Question 5. Change in Gearing or Leverage

Compare this year's gearing (long-term debt divided by average total assets) to last year's gearing.

Score 0 if this year's gearing is higher, 1 otherwise.

Gearing (This Year: Dec23)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Dec22 to Dec23
=0.84/100.8234
=0.0083314

Gearing (Last Year: Dec22)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Dec21 to Dec22
=1.848/127.968
=0.01444111

Sera Prognostics's gearing of this year was 0.0083314. Sera Prognostics's gearing of last year was 0.01444111. ==> This year is lower or equal to last year. ==> Score 1.

Question 6. Change in Working Capital (Liquidity)

Compare this year's current ratio (current assets divided by current liabilities) to last year's current ratio.

Score 1 if this year's current ratio is higher, 0 if it's lower

Current Ratio (This Year: Dec23)=Total Current Assets/Total Current Liabilities
=61.344/24.443
=2.50967557

Current Ratio (Last Year: Dec22)=Total Current Assets/Total Current Liabilities
=90.125/15.538
=5.80029605

Sera Prognostics's current ratio of this year was 2.50967557. Sera Prognostics's current ratio of last year was 5.80029605. ==> Last year's current ratio is higher ==> Score 0.

Question 7. Change in Shares in Issue

Compare the number of shares in issue this year, to the number in issue last year.

Score 0 if there is larger number of shares in issue this year, 1 otherwise.

Sera Prognostics's number of shares in issue this year was 31.417. Sera Prognostics's number of shares in issue last year was 31.018. ==> There is larger number of shares in issue this year. ==> Score 0.

Efficiency

Question 8. Change in Gross Margin

Compare this year's gross margin (Gross Profit divided by sales) to last year's.

Score 1 if this year's gross margin is higher, 0 if it's lower.

Gross Margin (This Year: TTM)=Gross Profit/Revenue
=0.096/0.306
=0.31372549

Gross Margin (Last Year: TTM)=Gross Profit/Revenue
=0.075/0.268
=0.27985075

Sera Prognostics's gross margin of this year was 0.31372549. Sera Prognostics's gross margin of last year was 0.27985075. ==> This year's gross margin is higher. ==> Score 1.

Question 9. Change in asset turnover

Compare this year's asset turnover (total sales for the year divided by total assets at the beginning of the year) to last year's asset turnover ratio.

Score 1 if this year's asset turnover ratio is higher, 0 if it's lower

Asset Turnover (This Year)=Revenue/Total Assets at the Beginning of This Year (Dec22)
=0.306/116.329
=0.00263047

Asset Turnover (Last Year)=Revenue/Total Assets at the Beginning of Last Year (Dec21)
=0.268/147.029
=0.00182277

Sera Prognostics's asset turnover of this year was 0.00263047. Sera Prognostics's asset turnover of last year was 0.00182277. ==> This year's asset turnover is higher. ==> Score 1.

Evaluation

Piotroski F-Score= Que. 1+ Que. 2+ Que. 3+Que. 4+Que. 5+Que. 6+Que. 7+Que. 8+Que. 9
=0+0+0+1+1+0+0+1+1
=4

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

Sera Prognostics has an F-score of 4 indicating the company's financial situation is typical for a stable company.

Sera Prognostics  (NAS:SERA) Piotroski F-Score Explanation

The developer of the system is Joseph D. Piotroski is relatively unknown accounting professor who shuns publicity and rarely gives interviews.

He graduated from the University of Illinois with a B.S. in accounting in 1989, received an M.B.A. from Indiana University in 1994. Five years later, in 1999, after earning a Ph.D. in accounting from the University of Michigan, he became an associate professor of accounting at the University of Chicago.

In 2000, he wrote a research paper called "Value Investing: The Use of Historical Financial Statement Information to Separate Winners from Losers" (pdf).

He wanted to see if he can develop a system (using a simple nine-point scoring system) that can increase the returns of a strategy of investing in low price to book (referred to in the paper as high book to market) value companies.

What he found was something that exceeded his most optimistic expectations.

Buying only those companies that scored highest (8 or 9) on his nine-point scale, or F-Score as he called it, over the 20 year period from 1976 to 1996 led to an average out-performance over the market of 13.4%.

Even more impressive were the results of a strategy of investing in the highest F-Score companies (8 or 9) and shorting companies with the lowest F-Score (0 or 1).

Over the same period from 1976 to 1996 (20 years) this strategy led to an average yearly return of 23%, substantially outperforming the average S&P 500 index return of 15.83% over the same period.


Sera Prognostics Piotroski F-Score Related Terms

Thank you for viewing the detailed overview of Sera Prognostics's Piotroski F-Score provided by GuruFocus.com. Please click on the following links to see related term pages.


Sera Prognostics (Sera Prognostics) Business Description

Traded in Other Exchanges
N/A
Address
2749 East Parleys Way, Suite 200, Salt Lake City, UT, USA, 84109
Sera Prognostics Inc is a health diagnostic company. It develops diagnostic tests for the early prediction of a woman's individualized risk of premature birth, preeclampsia, and other pregnancy complications.
Executives
John J. Boniface officer: Chief Scientific Officer C/O SERA PROGNOSTICS, INC., 2749 EAST PARLEYS WAY, SUITE 200, SALT LAKE CITY UT 84109
Benjamin Jackson officer: General Counsel 320 WAKARA WAY, SALT LAKE CITY UT 84108
Austin Aerts officer: Chief Financial Officer 2479 EAST PARLEYS WAY, SUITE 200, SALT LAKE CITY UT 84109
Robert Gardner Harrison officer: Chief Information Officer 320 WAKARA WAY, SALT LAKE CITY UT 84108
Jane F Barlow director 6800 BROKEN SOUND PARKWAY NW, 3RD FLOOR, BOCA RATON FL 33487
Michael R Foley officer: Chief Medical Officer C/O SERA PROGNOSTICS INC, 2749 EAST PARLEYS WAY SUITE 200, SALT LAKE CITY UT 04109
Sandra Aj Lawrence director C/O EVERGY, INC., 1200 MAIN STREET, KANSAS CITY MO 64105
Zhenya Lindgardt director C/O SERA PROGNOSTICS INC, 2749 EAST PARLEYS WAY SUITE 200, SALT LAKE CITY UT 84109
Paul Kearney officer: Chief Data Officer 2749 E. PARLEYS WAY, C/O SERA PROGNOSTICS, INC., SALT LAKE CITY UT 84109
Kim P. Kamdar director C/O DOMAIN ASSOCIATES, L.L.C., ONE PALMER SQUARE, SUITE 515, PRINCETON NJ 08542
Blue Ox Healthcare Partners, Llc 10 percent owner 239 DAWSON ROAD, HILLSIDE NY 12529
Nichole L. Martin officer: VP OF Q/R & HIPPA PRIV. OFF C/O SERA PROGNOSTICS, INC., 2749 EAST PARLEYS WAY, SUITE 200, SALT LAKE CITY UT 84109
Marcus Dean Wilson director C/O SERA PROGNOSTICS, INC., 2749 EAST PARLEYS WAY, SUITE 200, SALT LAKE CITY UT 84109
Joshua Phillips director C/O SERA PROGNOSTICS, INC., 2749 EAST PARLEYS WAY, SUITE 200, SALT LAKE CITY UT 84109
Nadia Altomare officer: Chief Commercial Officer C/O SERA PROGNOSTICS, INC., 2749 EAST PARLEYS WAY, SUITE 200, SALT LAKE CITY UT 84109